Related Experiment Video

Updated: Apr 14, 2026

Automated Joint Space Detection Improves Bone Segmentation Accuracy
06:45

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

294

Efficacy of tocilizumab on MRI-determined bone oedema in rheumatoid arthritis

Nada Bensaoud1, Samira Rostom, Rachid Bahiri

  • 1Mohammed Vth University, URAC 30, Department of Rheumatology, El Ayachi Hospital, Salé, Faculty of Medicine and Pharmacy, Rabat, Morocco, nadabensaoud@yahoo.fr.

Clinical Rheumatology
|April 24, 2015
PubMed

Insights

Tocilizumab treatment significantly reduced bone edema in rheumatoid arthritis patients, as evidenced by MRI scans. This improvement correlated with reduced disease activity, suggesting a potential early structural benefit.

Area of Science:

  • Rheumatology
  • Immunology
  • Radiology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
  • Bone edema is a key MRI finding in RA, often associated with disease activity and structural damage.
  • Tocilizumab, an IL-6 receptor inhibitor, is used to treat RA, but its effect on bone edema requires further investigation.

Purpose of the Study:

  • To evaluate the impact of tocilizumab on bone edema in RA patients using MRI.
  • To assess the correlation between changes in bone edema and disease activity parameters.

Main Methods:

  • Longitudinal study including RA patients treated with tocilizumab.
  • Disease activity assessed using DAS28, SDAI, and CDAI.
  • Hand MRI performed at baseline and 6 months to evaluate bone edema and synovitis using RAMRIS scoring.

Main Results:

  • Bone edema decreased or resolved in 32% of patients after 6 months of tocilizumab treatment.
  • Significant improvement observed in RAMRIS bone edema scores (p=0.04).
  • Significant improvements also noted in RAMRIS synovitis, DAS28, CRP, and SDAI.

Conclusions:

  • Tocilizumab treatment leads to significant short-term improvement in MRI-detected bone edema in RA patients.
  • The reduction in bone edema is associated with improved disease activity markers.
  • These findings suggest a potential early structural effect of tocilizumab in RA.

More Related Videos

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.5K
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis07:15

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

Published on: October 20, 2013

9.9K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
804
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
716
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
10.5K